Pharmacists expanded role in providing care for opioid use disorder during COVID-19: A qualitative study exploring pharmacists’ experiences

INTRODUCTION: During the COVID-19 pandemic, patients with opioid use disorder (OUD) struggled with access to prescribers and opioid agonist therapy (OAT). Recognizing this gap in care, Health Canada issued a short-term subsection 56(1) class exemption from the Controlled Drugs and Substances Act aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishop, Lisa D., Rosenberg-Yunger, Zahava R.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743855/
https://www.ncbi.nlm.nih.gov/pubmed/35032858
http://dx.doi.org/10.1016/j.drugalcdep.2022.109303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743855/
https://www.ncbi.nlm.nih.gov/pubmed/35032858
http://dx.doi.org/10.1016/j.drugalcdep.2022.109303

Ejemplares similares